GSE179235 MEK NRAS inhibition 0 v 7 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179235_MEK_NRAS inhibition_0_v_7_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179235_MEK_NRAS inhibition_0_v_7_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179235_MEK_NRAS inhibition_0_v_7_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179235_MEK_NRAS inhibition_0_v_7_human_up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 1291

Gene

long intergenic non-protein coding RNA 511

Gene

taxilin gamma Y-linked (pseudogene)

Gene

MIR3142 host gene

Gene

deleted in lymphocytic leukemia 2

Gene

glucosylceramidase beta 1 like, pseudogene

Gene

family with sequence similarity 27 member C

Gene

MIR4458 host gene

Gene

zinc finger protein 271, pseudogene

Gene

HOXA cluster antisense RNA 3

  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    taxilin gamma Y-linked (pseudogene)



  • Gene

    deleted in lymphocytic leukemia 2


  • Gene

    glucosylceramidase beta 1 like, pseudogene


  • Gene

    family with sequence similarity 27 member C



  • Gene

    zinc finger protein 271, pseudogene


  • Gene

    HOXA cluster antisense RNA 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.